Perrigo Company plc Cost of Goods Sold (Deprecated 2018-01-31)
Perrigo Company plc (PRGO) reported Cost of Goods Sold (Deprecated 2018-01-31) of $1.66 billion for the 6-month period ending 2015-12-31, per its 10-KT filed 2016-02-25.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2016-02-25
- Perrigo Company plc cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $2.89B, a 10.65% increase from fiscal 2014.
- Perrigo Company plc cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $2.61B, a 15.63% increase from fiscal 2013.
- Perrigo Company plc cost of goods sold (deprecated 2018-01-31) for fiscal 2013 was $2.26B.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|
| 2015-12-31 | $1.66B 10-KT · filed 2016-02-25 | |
| 2015-06-27 | $2.89B 10-KT · filed 2016-02-25 | |
| 2014-12-27 | $1.32B 10-KT · filed 2016-02-25 | |
| 2014-06-28 | $2.61B 10-KT · filed 2016-02-25 | |
| 2013-06-29 | $2.26B 10-KT · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |